Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intravenous tirofiban in acute ischemic stroke without large arterial occlusion
ChiCTR-OIN-17013510Phase 2Recruiting
- Sponsor
- Army Specialized Medical Center
- Start
- Dec 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of tirofiban in ischemic stroke (2 arms), sponsored by Army Specialized Medical Center. Primary endpoints: Intracerebral hemorrhage transformation, Severe bleeding and 3 more. Started Dec 2017; status: recruiting.
02
Drugs
tirofiban
03
Conditions
ischemic stroke
Beyond the preview
Go deeper on ChiCTR-OIN-17013510.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OIN-17013510.